#CDTX
On Monday, October 26, 2026, at College Park in San Jose, CA, northbound/eastbound Capitol Corridor Train 538 was shoved by California DOT (CDTX) 2005.

(Please see alt field for more detail)

#trains #railroads #railroading #capitolcorridor #transit #sanjose_ca #cdtx
November 6, 2026 at 6:21 AM
📢 Stocks Trending NOW: #TSLA #MSTR #CDTX #COIN #NVDA #IVVD #AVXL #WMT #ASBP #HOOD
November 14, 2025 at 2:20 PM
Night Street Receivers - Fixions

www.youtube.com/watch?v=CDTX...
Fixions - Night Streets Receivers
YouTube video by Fixions & ORR
www.youtube.com
October 21, 2024 at 2:52 AM
In an age if increasing vaccine skepticism, I like this approach from $CDTX - a once yearly prophylactic antiviral flu shot (not a vaccine, nor dependent on the immune system), which should work for all flu strains and work whatever the immune status of the patient finance.yahoo.com/news/cidara-...
Cidara Therapeutics Completes Enrollment of Phase 2b NAVIGATE Trial Evaluating CD388 for Prevention of Seasonal Influenza
SAN DIEGO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunothera...
finance.yahoo.com
December 4, 2024 at 1:57 PM
AMTK 777 w/ CDTX 6908 leading, near the ARTIC hub station. Taken 2/23/25.

#amtrak #trains
March 4, 2025 at 6:48 AM
$ARDT $CDTX $KRT $MT $PCH $RPTX $WY $AKAM $ANRO $AXON $BLD $BLDR $FSLY $IBP $MASI $NTAP $NTNX $OVID $PSTG $RBRK $TATT $VVOS -- MarketBeat
November 17, 2025 at 4:40 PM
$CDTX +88.7% [Merck wins bidding war for Cidara Therapeutics at $9.2B, more than double its market value, securing groundbreaking long-acting flu antibody treatment as Big Pharma races for cutting-edge medicines.] notreload.xyz/merck-wins-b...
Merck Wins $9.2B Bidding War for Cidara's Flu Drug Tech
Merck wins bidding war for Cidara Therapeutics at $9.2B, more than double its market value, securing groundbreaking long-acting flu antibody treatment as Big Pharma races for cutting-edge medicines.
notreload.xyz
November 14, 2025 at 10:49 AM
$IRD $AEP $AWK $AMBP $BALL $BMNR $CLS $CDTX $CLYM $COGT $CCK $DLR $DUK $EIX $EQIX $ERAS $ES $EXC $FGNX $IT $GTY $NAKA $MDU $NEE $PCG $PNW $PEG $METC $RVTY $RKLB $SBET $SO $SQNS $VERA $VST $VTEX $WEC $XEL $TSLA $ACLX -- THE WSJ
October 16, 2025 at 2:08 PM
$ABT $TIC $APTV $ATRO $CDTX $CRBG $FSBC $GLNG $GRDN $GYRE $KRMN $MNKD $NWBI $CATX $SARO $VIK $WFRD $ZYME -- THE WSJ
October 10, 2025 at 1:56 PM
$CDTX +5.9% [JPMorgan sets $200 price target for Cidara Therapeutics, citing "game-changing" flu treatment CD388 with projected $4B peak U.S. sales and 75% success probability.] notreload.xyz/jpmorgan-ini...
JPMorgan Sets $200 Target for Cidara on Flu Drug CD388 Potential
JPMorgan sets $200 price target for Cidara Therapeutics, citing "game-changing" flu treatment CD388 with projected $4B peak U.S. sales and 75% success probability
notreload.xyz
October 10, 2025 at 10:16 AM
$CDTX +9% [Cidara's long-acting non-vaccine drug, CD388, has received FDA Breakthrough Therapy designation for preventing seasonal influenza in vulnerable adults and adolescents.] notreload.xyz/cidara-cd388...
Cidara's CD388 Wins Breakthrough Flu Prevention Designation
Cidara's long-acting non-vaccine drug, CD388, has received FDA Breakthrough Therapy designation for preventing seasonal influenza in vulnerable adults and adolescents.
notreload.xyz
October 9, 2025 at 4:05 PM
$CDTX +14.8% [FDA fast-tracked Cidara's CD388 flu drug trial by 6 months. Only one successful trial is needed for approval. Including seniors (65+) means a bigger market (5M+ patients) & higher analyst price targets ($137), boosting the stock.] notreload.xyz/cidara-cd388...
Cidara's CD388: FDA Meeting Boosts Outlook
FDA fast-tracked Cidara's CD388 flu drug trial by 6 months. Only one successful trial is needed for approval. Including seniors (65+) means a bigger market (5M+ patients) & higher analyst price target...
notreload.xyz
September 24, 2025 at 2:27 PM
$CDTX +80% [Cidara's CD388 Phase 2b trial met goals, showing up to 76% protection from symptomatic flu. Well-tolerated with no safety signals, it's designed for once-per-season use and is a potential breakthrough. FDA meeting for Phase 3 submitted, stock rallied.] www.cidara.com/news/cidara-...
Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza - Cidara Therapeutics
The study met its primary and all secondary efficacy endpoints for all dose groups Single doses of 450mg, 300mg and 150mg of CD388 conferred 76%, 61% and 58% protection, respectively, from symptomatic...
www.cidara.com
June 23, 2025 at 12:00 PM
$ALKT, $ARDX, $BAM, $BBU, $BN, $CDTX, $ELDN, $EQX, $DRI, $NKE, $BPOP, $CRDO -- THE WSJ
June 18, 2025 at 1:55 PM